Role of thrombospondin-1-derived peptide, 4N1K, in FGF-2-induced angiogenesis

Experimental Cell Research

Volumn 252, Issue 2, 1999, Pages 262-272

  Kanda, Shigeru ^a   Shono, Takefumi ^a   Tomasini Johansson, Bianca ^b   Klint, Peter ^b   Saito, Yutaka ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

4N1K peptide; Angiogenesis; Endothelial cell; Thrombospondin 1; Tube formation

Indexed keywords

ANGIOGENESIS INHIBITOR; FIBROBLAST GROWTH FACTOR 2; THROMBOSPONDIN 1;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CAPILLARY ENDOTHELIUM; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN;

ANIMALIA; MURINAE;

EID: 0033230597     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4622     Document Type: Article

References (40)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other diseases. Nat. Med. 1:1995;27-31.
2. Holmgren L. Antiangiogenesis restricted tumor dormancy. Cancer Metastasis Rev. 15:1996;241-245.
3. Bicknell R., Harris A. L. Mechanisms and therapeutic implications of angiogenesis. Curr. Opin. Oncol. 8:1996;60-65.
4. Colville-Nash P. R., Willoughby D. A. Growth factors in angiogenesis: Current interest and therapeutic potential. Mol. Med. Today. 3:1997;14-23.
5. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
6. D'Amore P., Thompson R. W. Mechanisms of angiogenesis. Annu. Rev. Physiol. 49:1987;453-464.
7. Frazier W. A. Thrombospondins. Curr. Opin. Cell Biol. 3:1991;792-799.
8. Bornstein P. Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J. Cell Biol. 130:1995;503-506.
9. Bagavandoss P., Wilkes J. W. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem. Biophys. Res. Commun. 170:1990;867-872.
10. Good D. J., Polverini P. J., Ranstinejad F., Le Beau M. M., Lemons R. S., Frazier W. A., Bouck N. P. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment thrombospondin. Proc. Natl. Acad. Sci. USA. 87:1990;6624-6628.
11. Taraboletti G., Belotti D., Giavazzi R. Thrombospondin modulates basic fibroblast growth factor activities in endothelial cells. Steiner R., Weiss P. B., Langer R. Angiogenesis, Key Principles. 1992;Birkhauser Verlag, Basel.
12. Vogel T., Guo N. H., Krutsch H. C., Blake D. A., Hartman J., Mendelovitz S., Panet A., Roberts D. D. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from type I repeats of thrombospondin. J. Cell. Biochem. 53:1993;74-84.
13. RayChaudhury A., Frazier W. A., D'Amore P. A. Comparison of normal and tumorigenic endothelial cells: Differences in thrombospondin production and responses to transforming growth factor β J. Cell Sci. 107:1994;39-46.
14. Rastinejad F., Polverini P. J., Bouck N. P. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell. 56:1989;345-355.
15. Taraboletti G., Roberts D., Liotta L. A., Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility and growth: A potential angiogenesis regulatory factor. J. Cell Biol. 111:1990;765-772.
16. Tolsma S. S., Volpert O. V., Good D. J., Frazier W. A., Pelverini P. J., Bouck N. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. J. Cell Biol. 122:1993;497-511.
17. Iruela-Arispe M. L., Bornstein P., Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;5026-5030.
18. Canfield A. E., Schor A. M. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J. Cell Sci. 108:1995;797-809.
19. Tolsma S. S., Stack M. S., Bouck N. Lumen formation and other angiogenic activities of cultured capillary endothelial cells are inhibited by thrombospondin-1. Microvasc. Res. 54:1997;13-26.
20. Reed M. J., Iruela-Arispe L., O'Brien E. R., Truong T., LaBell T., Bornstein P., Sage H. Expression of thrombospondins by endothelial cells: Injury is correlated with TSP-1. Am. J. Pathol. 147:1995;1068-1080.
21. DiPietro L. A., Nebgen D. R., Pelverini P. J. Downregulation of endothelial cell thrombospondin 1 enhances in vitro angiogenesis. J. Vasc. Res. 31:1994;178-185.
22. Dameron K. M., Volpert O. V., Tainsky M. A., Bouck N. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science. 265:1994;1582-1584.
23. Gao A-G., Lindberg F. P., Finn M. B., Blystone S. D., Brown E. J., Frazier W. A. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J. Biol. Chem. 271:1996;21-24.
24. Dawson D. W., Pearce S. F. A., Zhong R., Silverstein R. L., Frazier W. A., Bouck N. P. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells. J. Cell Biol. 138:1997;707-717.
25. Greenwood J. A., Pallero M. A., Theibert A. B., Murphy-Ullrich J. E. Thrombospondin signaling of focal adhesion disassembly requires activation of phosphoinositide 3-kinase. J. Biol. Chem. 273:1998;1755-1763.
26. Kanda S., Landgren E., Ljungström M., Claesson-Welsh L. Fibroblast growth factor receptor 1-induced differentiation of an endothelial cell line established from tsA58 large T transgenic mice. Cell Growth Differ. 7:1996;383-395.
27. Rahmanian M., Pertoft H., Kanda S., Christofferson R., Claesson-Welsh L., Heldin P. Hyaluronan oligosaccharides induce tube formation of a brain endothelial cell line in vitro. Exp. Cell Res. 237:1997;223-230.
28. Kanda S., Tomasini-Johansson B., Klint P., Dixelius J., Rubin K., Claesson-Welsh L. Signaling via fibroblast growth factor receptor-1 is dependent on extracellular matrix in capillary endothelial cell differentiation. Exp. Cell Res. 248:1999;203-213.
29. Kanda S., Nomata K., Saha P. K., Nishimura N., Yamada J., Kanetake H., Saito Y. Growth regulation of the renal cortical tubular cells by epidermal growth factor, insulin-like growth factor-I, acidic and basic fibroblast growth factor, and transforming growth factor-β in serum free culture. Cell Biol. Int. Rep. 13:1989;687-699.
30. 3 function through integrin-associated protein. J. Cell Biol. 135:1996;533-544.
31. v integrins. Science. 270:1995;1500-1502.
32. 1 integrins. J. Biol. Chem. 269:1994;20233-20238.
33. Kanda S., Hodgkin M. N., Woodfield R. J., Wakelam M. J. O., Thomas G., Claesson-Welsh L. Phosphatidylinositol 3′-kinase-independent p70 S6 kinase activation by fibroblast growth factor receptor-1 is important for proliferation but not differentiation of endothelial cells. J. Biol. Chem. 272:1997;23347-23353.
34. Chen C., Parangi S., Tolentino M. J., Folkman J. A strategy to discover circulation angiogenesis inhibitors generated by human tumors. Cancer Res. 55:1995;4230-4233.
35. 1 integrin in vascular smooth muscle cells. Mol. Biol. Cell. 9:1998;865-874.
36. 2+ flux but not mitogenesis. Nature. 358:1992;678-681.
37. Mohammadi M., Dionne C. A., Li W., Li N., Spivak T., Honegger A. M., Jaye M., Schlessinger J. Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature. 358:1992;681-684.
38. Klint P., Kanda S., Kloog Y., Claesson-Welsh L. Contribution of Src and Ras pathways in FGF-2-induced endothelial differentiation. Oncogene. 18:1999;3354-3364.
39. 3 and integrin-associated protein. J. Cell Biol. 130:1995;745-754.
40. 3 for angiogenesis. Science. 264:1994;569-571.